Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Well Care Compounding Pharmacy

Well Care Compounding Pharmacy Recalls

All product recalls associated with Well Care Compounding Pharmacy.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

May 2016

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–51 of 51 recalls

Methyl B12 (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Phosphatidylcholine/Deoxycholic Acid (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Phenylepherine (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class II

1 23

Page 3 of 3Next

Moderate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Levocarnitine 100mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Quad-Mix #1 Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Tri-Mix #3 Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Testosterone Cypionate 150mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Testosterone Cypionate 175mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

M.I.C. Multivitamin Injection (Well Care Compounding) – Sterility Concern (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Tri-Mix #1 (Well Care Compounding) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Glutathione 100MG/ML (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy